Novo Nordisk Warns of First Sales Drop Since Start of Ozempic

New York Times - Feb 4, 2026

The once high-flying Danish drugmaker has struggled to fend off rivals in the weight-loss industry, especially Eli Lilly, which gave a much rosier outlook to investors.

Read full article
More News
ABOUT US
Logo

Market Sanctum is one of the world’s leading news sources for the currency trading community. We have experts in the industry to share about business news and real-time commentary together with dedicated journalists reporting on stories and market briefs in the U.S., Europe, and Asia.

Contact us: sales[at]marketsanctum.com


SUBSCRIBE
Copyright © 2015 - 2026 Market Sanctum. All Rights Reserved.